Public Company Healthcare

Hologic

Marlborough, Massachusetts, United States

Innovative medical technology company focused on improving women’s health through early detection and treatment, with core areas across Breast & Skeletal Health, Diagnostic Solutions, and GYN Surgical Solutions.

Focus Areas
Women’s health medical technology, Diagnostics, Minimally invasive gynecologic surgery
Website
www.hologic.com

Tracked deals

5

5 tracked deals across 2020-2025.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

4 buyout · 1 addon

Hologic Acquisition Volume by Year

Last 4 years

Acquisition volume by year Annual acquisition counts for the last 4 years for Hologic. 1 2020 1 2021 2 2024 1 2025

Supporting Data

Recent Transactions

  • January 6, 2025
    Buyer
    Hologic, Inc.
    Target
    Gynesonics, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    Hologic, Inc. completed its previously announced acquisition of Gynesonics, a privately held medical device company focused on minimally invasive solutions for women’s health, for about $350 million. Gynesonics develops the Sonata System for diagnostic intrauterine imaging and incision-less transcervical treatment of certain symptomatic uterine fibroids.

  • Buyer
    Hologic, Inc.
    Target
    Endomagnetics Ltd (Endomag)
    Industry
    Medical Devices
    Location
    United Kingdom
    Type
    Buyout

    Hologic signed a definitive agreement to acquire Endomagnetics Ltd (Endomag), a Cambridge, United Kingdom-based developer of breast cancer surgical guidance technologies, for approximately $310 million. The deal is subject to customary closing conditions, including regulatory approvals, and Endomag’s wireless breast surgery localization and lymphatic tracing solutions are expected to complement Hologic’s breast surgery portfolio.

  • Buyer
    Maverix Medical, Ajax Health, KKR, Hologic, Inc.
    Target
    Cirrus Bio
    Industry
    Biotechnology
    Location
    United States
    Type
    Addon

    Maverix Medical, a lung cancer platform backed by Ajax Health, KKR, and Hologic, has acquired Cirrus Bio to form the foundation of a new diagnostics division, Maverix Dx. Cirrus Bio's multiomic diagnostic capabilities and its founders, David Mallery (CEO) and Scott Morris (CSO), will lead Maverix Dx as the platform pursues further diagnostic product development and M&A.

  • Buyer
    Hologic, Inc.
    Target
    Bolder Surgical
    Type
    Buyout

    Hologic, Inc. has completed its previously announced acquisition of Bolder Surgical, a privately held U.S. provider of advanced energy vessel sealing surgical devices, for approximately $160 million. The deal expands Hologic’s surgical portfolio with laparoscopic vessel sealing, dividing and dissection tools and enables broader use of Bolder’s devices by OB/GYN specialists.

  • Buyer
    Hologic, Inc.
    Target
    Acessa Health Inc.
    Industry
    Medical Devices
    Type
    Buyout

    Hologic, Inc. has acquired Acessa Health Inc., a privately held maker of the Acessa ProVu minimally invasive system for treating uterine fibroids, for approximately $80 million in cash plus contingent payments. The tuck-in purchase expands Hologic's GYN surgical portfolio and leverages Hologic's commercial infrastructure to accelerate adoption of Acessa's technology.

Related Acquisition Pages

Selling a company? Get in front of buyers like Hologic

Turn tracked acquisition activity into an outreach-ready buyer list.